Get the Stockscreener App
0.6297
3.08%
-0.0203
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Vaxart Inc stock is traded at $0.6297, with a volume of 223.96K.
It is down -3.08% in the last 24 hours and down -13.70% over the past month.
VAXART INC
See More
Previous Close:
$0.65
Open:
$0.62
24h Volume:
223.96K
Relative Volume:
0.69
Market Cap:
$N/A
Revenue:
$237.26M
Net Income/Loss:
$16.33M
P/E Ratio:
10.62
EPS:
0.0593
Net Cash Flow:
$7.57M
1W Performance:
-9.22%
1M Performance:
-13.70%
6M Performance:
+61.54%
1Y Performance:
-35.85%
1-Day Range:
$0.60
$0.6452
1-Week Range:
$0.60
$0.7038
52-Week Range:
$0.33
$0.80
Vaxart Inc Stock (VXRT) Company Profile
Compare VXRT vs VRTX, REGN, ARGX, ALNY, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VXRT
Vaxart Inc
|
0.6297 | 0 | 237.26M | 16.33M | 7.57M | 0.0593 |
VRTX
Vertex Pharmaceuticals Inc
|
448.10 | 113.44B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
777.50 | 81.68B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
743.99 | 45.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.86 | 43.88B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
164.97 | 35.25B | 606.42M | -1.28B | -997.58M | -6.403 |
Vaxart Inc Stock (VXRT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-15-24 | Initiated | Oppenheimer | Outperform |
| Dec-29-21 | Resumed | Jefferies | Buy |
| Nov-02-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-29-21 | Downgrade | B. Riley Securities | Buy → Neutral |
| Jun-24-21 | Initiated | Jefferies | Buy |
| Jun-11-21 | Initiated | Piper Sandler | Overweight |
| Aug-12-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-13-20 | Initiated | B. Riley FBR | Buy |
View All
Vaxart Inc Stock (VXRT) Latest News
Tax withholding trims Vaxart (NASDAQ: VXRT) SVP Sean Tucker RSU shares - Stock Titan
Vaxart (NASDAQ: VXRT) CMO shares withheld to cover RSU tax obligations - Stock Titan
VXRT (Vaxart) Purchase Of Investment : $-23.2 Mil (TTM As of Dec. 2025) - GuruFocus
Vaxart (NASDAQ: VXRT) SVP Berg has 36,418 shares withheld for RSU tax obligations - Stock Titan
Vaxart (VXRT) CMO settles RSU taxes with 30,551 withheld shares - Stock Titan
Vaxart (NASDAQ: VXRT) CEO has shares withheld to cover RSU taxes - Stock Titan
Vaxart (NASDAQ: VXRT) SVP Sean Tucker reports RSU tax-withholding event - Stock Titan
Swing Trade: What drives Par Pacific Holdings Incs stock priceStock Surge & Risk Controlled Daily Plans - baoquankhu1.vn
Vaxart (VXRT) SVP Berg has 8,072 shares withheld to cover RSU taxes - Stock Titan
Vaxart (VXRT) CMO reports 6,772-share tax withholding, holds 958,020 shares - Stock Titan
Vaxart (VXRT) CEO Steven Lo reports RSU tax withholding of 22,425 shares - stocktitan.net
Vaxart (VXRT) SVP Sean Tucker reports RSU tax-withholding disposition - Stock Titan
Vaxart, Inc. (NASDAQ:VXRT) Q4 2025 Earnings Call Transcript - Insider Monkey
Vaxart (VXRT) CEO Steven Lo receives major stock option and RSU grants - stocktitan.net
Vaxart (VXRT) CSO Sean Tucker awarded 410K options and 200K shares - Stock Titan
Vaxart (VXRT) CFO granted 227,000 shares and 455,000 options in Form 4 - Stock Titan
Vaxart (NASDAQ: VXRT) CMO receives new stock options and RSUs - Stock Titan
Vaxart (NASDAQ: VXRT) SVP and General Counsel granted shares and options - Stock Titan
Trading Recap: Is Vaxart Inc a play on infrastructure spendingCPI Data & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Risk Off: Is Vaxart Inc still a buy after recent gainsWeekly Trade Recap & Community Trade Idea Sharing - baoquankhu1.vn
Vaxart (VXRT) Short Interest & Short Float | Updated Mar 2026 $VXRT - MarketBeat
High-Potential Stocks Under $5 to Watch in 2026 - TradingKey
Vaxart (VXRT) Revenue Surge To US$72.4 Million Tests Bearish Decline Narrative - simplywall.st
VXRT: Oral vaccine platform advances with global partnerships, cost savings, and key data expected in 2026 - TradingView
Vaxart (OTCMKTS:VXRT) Releases Quarterly Earnings Results, Beats Expectations By $0.32 EPS - MarketBeat
Vaxart, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Vaxart (OTCQX: VXRT) outlines progress on oral norovirus and COVID vaccines - Stock Titan
Vaxart signals $700M COVID-19 vaccine milestone path as Sanofi partnership advances and 2026 data readouts approach - MSN
Vaxart Q4 Earnings Call Highlights - MarketBeat
Vaxart Inc (VXRT) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Partnerships Propel Growth - GuruFocus
Vaxart (VXRT) Reports Strong Revenue Growth in 2025 - GuruFocus
Vaxart Q4 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Vaxart’s Q4 2025 revenue surges, stock reacts - Investing.com
VAXART ($VXRT) Releases Q4 2025 Earnings - Quiver Quantitative
Vaxart (OTCQX: VXRT) turns 2025 profit as revenue jumps to $237M - Stock Titan
Vaxart, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Vaxart (VXRT) Set to Release Q4 Earnings Report - GuruFocus
Vaxart Q4 2025 earnings preview - msn.com
Vaxart (VXRT) to Release Earnings on Thursday - MarketBeat
Why Vaxart Inc. stock attracts high net worth investorsQuarterly Trade Summary & Weekly High Return Forecasts - Naître et grandir
RFK Jr. pauses $240 million contract for new ‘oral COVID vaccine’ - todayville.com
Vaxart to Host Upcoming Conference Calls - The Manila Times
VXRT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Is Vaxart's (VXRT) Conference Spotlight Reframing the Oral Vaccine Story or Just Polishing It? - Yahoo Finance
Vaxart, Inc. (VXRT) Presents at Oppenheimer 36th Annual Healthcare Life Sciences ConferenceSlideshow - Seeking Alpha
3 Stocks Under $5 With Strong Analyst Upside Potential - Investing.com
3 Stocks Under $5 With Strong Analyst Upside Potential - Investing.com
Vaxart (OTCMKTS:VXRT) Stock Price Passes Above Fifty Day Moving AverageWhat's Next? - MarketBeat
Vaxart (VXRT) Earnings Date and Reports 2026 $VXRT - MarketBeat
Vaxart (VXRT) Stock Price, News & Analysis $VXRT - MarketBeat
Vaxart (VXRT) Institutional Ownership 2026 $VXRT - MarketBeat
Vaxart Inc Stock (VXRT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.44%
Cap:
|
Volume (24h):